外体生物标志物和免疫检查点抑制剂:进展和未来前景
Can Lu1,2, Muhammad Tufail1, Can-Hua Jiang1,3,4,5
1Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China.
Cancer cell international
|June 24, 2025
概括
外体和它们的生物标志物在预测癌症治疗对免疫检查点抑制剂 (ICI) 的反应方面表现有前途. 需要进一步的研究来克服个性化免疫疗法策略的挑战.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 免疫检查点抑制剂 (ICI) 已经改变了癌症治疗,但很难预测患者的反应.
- 外基因组参与细胞通信,正在成为癌症进展和治疗反应的关键参与者.
- 了解外体细胞的功能对于改善癌症免疫治疗结果至关重要.
研究的目的:
- 审查外体和循环外体生物标志物在预测ICI反应中的作用.
- 探索ICI的机制和瘤微环境对免疫反应的影响.
- 确定癌症免疫治疗中外体生物标志物的挑战和未来方向.
主要方法:
- 对外体,ICI和癌症治疗的当前研究的文献综述.
- 对外体载荷,分子组成和免疫调节功能的分析.
- 讨论临床翻译的挑战和未来的前景.
主要成果:
- 外体和外体生物标志物显示出监测和预测ICI疗效的潜力.
- 外体生物标志物可以反映瘤和免疫系统的动态变化.
- 关于外体载荷对治疗结果的影响,仍然存在重大知识差距.
结论:
- 外体生物标志物为个性化癌症免疫疗法提供了一个有希望的途径.
- 标准化,敏感性和理解外体细胞功能是临床翻译的关键挑战.
- 未来的研究应该专注于利用外体生物标志物来优化ICI治疗策略.
更多相关视频
相关概念视频
01:36Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675